Clinical Trials Browser

Phase 2 × NIH × ispinesib × Clear all

NCT00095628 2017-03-06

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

21 enrolled 10 charts

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms

NCT00103311 2015-03-02

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Phase 2 Completed

64 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00354250 2013-06-05

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00095953 2013-05-17

SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00096499 2013-01-25

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Phase 2 Completed

Prostatic Neoplasms